Transcripts CNS Pharmaceuticals, Inc.

Actions

Marché Fermé - Nasdaq 22:30:00 08/10/2026			Varia. 5j.	Varia. 1 janv.
5,350 ^USD	-1,47 %		+2,09 %	+1,90 %

30/09	Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call
12/08	CNS Pharmaceuticals, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

30/09	Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call
17/06	Transcript : CNS Pharmaceuticals, Inc. - Special Call
17/11	Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call
11/12/24	Transcript : CNS Pharmaceuticals, Inc. - Analyst/Investor Day
26/08/24	Transcript : CNS Pharmaceuticals, Inc. Presents at Virtual Investor CEO Connect, Aug-26-2024 12:00 PM
30/07/24	Transcript : CNS Pharmaceuticals, Inc. - Special Call
30/04/24	Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call
23/04/24	Transcript : CNS Pharmaceuticals, Inc. - Special Call
18/10/23	Transcript : CNS Pharmaceuticals, Inc. - Pre Recorded Special Call
03/05/23	Transcript : CNS Pharmaceuticals, Inc. - Special Call
06/12/22	Transcript : CNS Pharmaceuticals, Inc. - Special Call
18/11/21	Transcript : CNS Pharmaceuticals, Inc. Presents at Virtual Investor Roundtable Event, Nov-18-2021 09:00 AM
09/03/21	Transcript : CNS Pharmaceuticals, Inc. Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM
18/12/20	Transcript : CNS Pharmaceuticals, Inc. - Special Call
12/11/20	Transcript : CNS Pharmaceuticals, Inc. - Special Call
22/09/20	Transcript : CNS Pharmaceuticals, Inc. Presents at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, Sep-22-2020 10:00 AM
13/08/20	Transcript : CNS Pharmaceuticals, Inc. - Special Call
22/04/20	Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call